Nutrition as a Determinant of Labor Outcome
Nutrition as Determinant of Labor Outcome
1 other identifier
interventional
200
1 country
1
Brief Summary
This is a randomized, double-blind trial looking at how nutrition intake is associated with labor progress and complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2006
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 22, 2006
CompletedFirst Posted
Study publicly available on registry
August 23, 2006
CompletedStudy Start
First participant enrolled
September 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedJuly 6, 2011
May 1, 2010
2.1 years
August 22, 2006
July 3, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The course of the labor by women (parity 0) at gestational age > 36 weeks, including: total labor time
At time of birth
Secondary Outcomes (4)
Length of stage 1 (cervical opening < 10 cm) and stage 2 (pushing time)
Use of epidural anesthetics
Use of contraction-stimulating drugs
Instrumental delivery
Interventions
Commercial energy/sports drink
Eligibility Criteria
You may qualify if:
- Women at gestational age \> 36 weeks, parity 0
You may not qualify if:
- Gestational age \< 36 weeks
- Signs of fetal pathology:
- Different or abnormal (pathological) CTG test performed just before start of the test
- Abnormal Doppler registrations (PI in the arteria umbilicae \> 2SD for the gestational age)
- Established notch in the arteria uterinae or notch bilaterally or PI \> 2SD \> 24 weeks
- Diverging in the weight of the fetus \> - 22% or diverging in the growth of the fetus - 10% or more, and established structural pathology in the fetus, oligohydramnion (amniotic fluid index \< 6)
- Maternal diseases and pregnancy complications
- diabetes in pregnancy
- high blood pressure
- cardiovascular diseases
- rheumatic disease
- epilepsia
- lung disease, etc.
- CTG test: cardiotocographic test (a measure of fetal activity)
- PI: pulsatory index (velocity pattern)
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oslo University Hospitallead
- University of Oslocollaborator
Study Sites (1)
Kristin Kardel
Oslo, 0027, Norway
Study Officials
- PRINCIPAL INVESTIGATOR
Tore Henriksen, MD
Oslo University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 22, 2006
First Posted
August 23, 2006
Study Start
September 1, 2006
Primary Completion
October 1, 2008
Study Completion
December 1, 2009
Last Updated
July 6, 2011
Record last verified: 2010-05